DOCSLIB.ORG

Recombinant Viruses As Vaccines Against Viral Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Recombinant Viruses As Vaccines Against Viral Diseases BrazilianRecombinant Journal viruses of Medical as vaccines and Biological Research (2005) 38: 509-522 509 ISSN 0100-879X Review Recombinant viruses as vaccines against viral diseases A.P.D. Souza1, 1Departamento de Microbiologia e Parasitologia, L. Haut1, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil A. Reyes-Sandoval2 2Wellcome Trust Centre for Human Genetics, University of Oxford, and A.R. Pinto1 Roosevelt Drive, Oxford, UK Abstract Correspondence Vaccine approaches to infectious diseases are widely applied and Key words A.R. Pinto appreciated. Amongst them, vectors based on recombinant viruses • Vaccine Departamento de Microbiologia e have shown great promise and play an important role in the develop- • Immunity Parasitologia, UFSC ment of new vaccines. Many viruses have been investigated for their • Recombinant viruses 88040-900 Florianópolis, SC ability to express proteins from foreign pathogens and induce specific • Viral vectors Brasil • Infectious disease Fax: +55-48-331-9258 immunological responses against these antigens in vivo. Generally, E-mail: [email protected] gene-based vaccines can stimulate potent humoral and cellular im- mune responses and viral vectors might be an effective strategy for A.R. Pinto is supported by Fundação both the delivery of antigen-encoding genes and the facilitation and de Ciência e Tecnologia do Estado enhancement of antigen presentation. In order to be utilized as a de Santa Catarina (FUNCITEC) and vaccine carrier, the ideal viral vector should be safe and enable Programa Nacional de DST/AIDS, efficient presentation of required pathogen-specific antigens to the Ministério da Saúde, Brasil. immune system. It should also exhibit low intrinsic immunogenicity to allow for its re-administration in order to boost relevant specific immune responses. Furthermore, the vector system must meet criteria Received August 30, 2004 that enable its production on a large-scale basis. Several viral vaccine Accepted February 21, 2005 vectors have thus emerged to date, all of them having relative advan- tages and limits depending on the proposed application, and thus far none of them have proven to be ideal vaccine carriers. In this review we describe the potential, as well as some of the foreseeable obstacles associated with viral vaccine vectors and their use in preventive medicine. Introduction smallpox infections. Since then, smallpox has been eradicated worldwide and other Vaccination has been one of the most diseases such as poliomyelitis have virtually important interventions designed to prevent disappeared in countries of the Western Hemi- disease to be employed on a worldwide ba- sphere and it is expected that some of these sis, second only to the improvement of sani- diseases will become globally eradicated in tation services and the provision of clean the near future. Also, vaccination has effec- drinking water. The concept of vaccinology tively limited the spread of many childhood originated in the 18th century when the En- and adult diseases, including measles, glish physician Edward Jenner used cowpox mumps, rubella, and hepatitis B. However, virus inoculations in an attempt to combat efforts to develop vaccines for remaining or Braz J Med Biol Res 38(4) 2005 510 A.P.D. Souza et al. emerging infectious agents, like malaria, components of the immune system, such as AIDS, herpes, dengue fever, and some viral antigen-presenting cells. A wide range of hepatitis have been futile. Despite consider- viruses have been extensively studied for able efforts, no licensed vaccines have yet their potential as recombinant vaccines and been produced against any parasitic or fun- although each of them has its own unique gal human disease. These difficulties are characteristics, they all have the ability to caused by the failure to clearly define anti- induce not just humoral, but also cellular gen targets that induce specific and broad immune responses. combinations of cellular, humoral and mu- This review provides details on three cosal immune responses that can prevent viral vaccine vector systems (poxvirus, ad- infection and limit progression of the dis- enovirus, and alphavirus) receiving consid- ease, without the risk of using live, attenu- erable attention in the literature and consid- ated vaccines. Consequently, new technolo- ered by the authors as the most advanced. In gies are required to develop better and safer addition, two other promising viral vectors vaccines. (poliovirus and herpesvirus), still in the ini- Novel approaches require a much more tial stages of their development for use as detailed characterization of the genetic or- vaccine vectors, will be discussed briefly. ganization of the pathogen and the genes Some disadvantages of these systems will responsible for virulence or induction of also be discussed, and some potential solu- immunity. As a result of this increased knowl- tions on how to circumvent these shortcom- edge and ability to manipulate the genomes ings are offered. of pathogens, we are in an unprecedented position to develop better live vectored vac- Poxvirus cines that are safe and able to induce a wide range of protective immune responses in- Members of the Poxviridae family are cluding humoral and cellular immunity, as the most commonly used and best character- well as systemic and mucosal immunity. ized viral vectors for vaccine purposes. The Presently, two approaches have been widely success of the World Health Organization investigated: DNA vaccines and recombi- (WHO)’s smallpox eradication program nant viruses. DNA vaccines have been ex- through the use of vaccinia virus, along with tensively reviewed elsewhere (1). Recombi- the development of genetic manipulation nant viruses represent a particularly promis- techniques for these viruses, have led to the ing avenue of vaccine research, both for development of poxviruses as genetic vec- improving existing vaccines and for devel- tors for genes from many pathogenic organ- oping new ones. This process normally in- isms. These vectors were developed in the volves taking a proven safe and efficacious early eighties by cloning a foreign DNA into vaccine virus, such as vaccinia or adenovi- the genome of vaccinia virus, and the poten- rus, and modifying its genome to include tial of recombinant vaccinia viruses as vac- genes coding for immunogenic proteins from cine vectors was recognized immediately other pathogens. Virus-derived vectors offer after their development (2). several potential advantages over traditional Poxviruses are large viruses containing vaccine technologies. These include, most complex DNA genomes ranging in size be- notably, high-level production of protein tween 130 to 300 kb pairs with a hairpin loop antigens directly within cells of the immu- at each end (3). Although they are DNA nized host, potential adjuvant effects of the viruses, their replication occurs in the cyto- viral delivery system itself and the possibil- plasm of the infected cell due to the presence ity of efficient delivery of antigen directly to of a transcription machinery in the virions. Braz J Med Biol Res 38(4) 2005 Recombinant viruses as vaccines 511 The family Poxviridae is divided into two accept less than 5 kb of genetic material (4). subfamilies, one of which, Chordopoxviri- The possibility of introducing large amounts dae, comprises the poxviruses of vertebrates. of DNA without disrupting viral stability Chordopoxviridae consists of eight genera allows for the insertion of several antigens that are able to infect vertebrates; the genera even from different pathogens in the same Orthopoxvirus and Avipoxvirus have been recombinant vector, as has been shown with widely engineered to be used as recombinant the insertion of the hepatitis B virus surface vectors for vaccine purposes. Variola virus, antigen, the herpes simplex virus glycopro- the causative agent of smallpox, and vac- tein D and the influenza virus hemagglutinin cinia virus, used in the smallpox vaccine, in the same vaccinia vector that generated an belong to the genus Orthopoxvirus and immune response to all three transgenic pro- fowlpox and canarypox are two viruses be- teins upon injection in rabbits (5). longing to the genus Avipoxvirus. Recombinant technology utilizing vac- Certain characteristics make poxviruses cinia virus began around the time that the suitable for use as vaccine vectors. Impor- WHO declared smallpox eradicated in 1980 tantly, these vectors are very stable and, and recommended that the use of vaccinia when lyophilized, they can be refrigerated virus for vaccine purposes be discontinued. and used even after 2 months. They are easy Nevertheless, recombinant vaccinia vectors to manufacture at a low cost and, further- became an attractive tool for the study of the more, have the potential to be administered molecular biology of poxvirus for in vitro by different routes, as shown by their safe production of proteins and as a recombinant delivery by the intradermal, intranasal, intra- vaccine. The most useful strategy to make vaginal, and intrarectal routes to generate recombinant vaccinia vectors has been ho- antibody and T-cell responses. Oral admin- mologous DNA recombination within in- istration of vaccinia recombinants has been fected cells, a process that occurs naturally shown to generate both mucosal and sys- during viral replication. The use of plasmid temic immune responses to the recombinant vectors for DNA recombination which con- protein. Finally, preexisting immunity to vac- tain the complete expression
Load more

Recommended publications
  • Genomic Characterisation of a Novel Avipoxvirus Isolated from an Endangered Yellow-Eyed Penguin (Megadyptes Antipodes)
    viruses Article Genomic Characterisation of a Novel Avipoxvirus Isolated from an Endangered Yellow-Eyed Penguin (Megadyptes antipodes) Subir Sarker 1,* , Ajani Athukorala 1, Timothy R. Bowden 2,† and David B. Boyle 2 1 Department of Physiology, Anatomy and Microbiology, School of Life Sciences, La Trobe University, Melbourne, VIC 3086, Australia; [email protected] 2 CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, VIC 3220, Australia; [email protected] (T.R.B.); [email protected] (D.B.B.) * Correspondence: [email protected]; Tel.: +61-3-9479-2317; Fax: +61-3-9479-1222 † Present address: CSIRO Australian Animal Health Laboratory, Australian Centre for Disease Preparedness, Geelong, VIC 3220, Australia. Abstract: Emerging viral diseases have become a significant concern due to their potential con- sequences for animal and environmental health. Over the past few decades, it has become clear that viruses emerging in wildlife may pose a major threat to vulnerable or endangered species. Diphtheritic stomatitis, likely to be caused by an avipoxvirus, has been recognised as a signifi- cant cause of mortality for the endangered yellow-eyed penguin (Megadyptes antipodes) in New Zealand. However, the avipoxvirus that infects yellow-eyed penguins has remained uncharacterised. Here, we report the complete genome of a novel avipoxvirus, penguinpox virus 2 (PEPV2), which was derived from a virus isolate obtained from a skin lesion of a yellow-eyed penguin. The PEPV2 genome is 349.8 kbp in length and contains 327 predicted genes; five of these genes were found to be unique, while a further two genes were absent compared to shearwaterpox virus 2 (SWPV2).
    [Show full text]
  • Diversity and Evolution of Novel Invertebrate DNA Viruses Revealed by Meta-Transcriptomics
    viruses Article Diversity and Evolution of Novel Invertebrate DNA Viruses Revealed by Meta-Transcriptomics Ashleigh F. Porter 1, Mang Shi 1, John-Sebastian Eden 1,2 , Yong-Zhen Zhang 3,4 and Edward C. Holmes 1,3,* 1 Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life & Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia; [email protected] (A.F.P.); [email protected] (M.S.); [email protected] (J.-S.E.) 2 Centre for Virus Research, Westmead Institute for Medical Research, Westmead, NSW 2145, Australia 3 Shanghai Public Health Clinical Center and School of Public Health, Fudan University, Shanghai 201500, China; [email protected] 4 Department of Zoonosis, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing 102206, China * Correspondence: [email protected]; Tel.: +61-2-9351-5591 Received: 17 October 2019; Accepted: 23 November 2019; Published: 25 November 2019 Abstract: DNA viruses comprise a wide array of genome structures and infect diverse host species. To date, most studies of DNA viruses have focused on those with the strongest disease associations. Accordingly, there has been a marked lack of sampling of DNA viruses from invertebrates. Bulk RNA sequencing has resulted in the discovery of a myriad of novel RNA viruses, and herein we used this methodology to identify actively transcribing DNA viruses in meta-transcriptomic libraries of diverse invertebrate species. Our analysis revealed high levels of phylogenetic diversity in DNA viruses, including 13 species from the Parvoviridae, Circoviridae, and Genomoviridae families of single-stranded DNA virus families, and six double-stranded DNA virus species from the Nudiviridae, Polyomaviridae, and Herpesviridae, for which few invertebrate viruses have been identified to date.
    [Show full text]
  • First Phylogenetic Analysis of Avipoxvirus (APV) in Brazil1
    Pesq. Vet. Bras. 36(5):357-362, maio 2016 DOI: 10.1590/S0100-736X2016000500001 First phylogenetic analysis of Avipoxvirus (APV) in Brazil1 2 2 2 2 3 2 2 4 Hiran C. Kunert-Filho *, Samuel P. Cibulski , Fabrine2 Finkler , Tiela T. Grassotti , Fátima R.F. Jaenisch , Kelly C.T. de Brito , Daiane Carvalho , Maristela Lovato ABSTRACT.- and Benito G. de Brito First phylogenetic analysis of Avipoxvi- rus (APV) in Kunert-FilhoBrazil. Pesquisa H.C., Veterinária Cibulski S.P., Brasileira Finkler 36(5):357-362F., Grassotti T.T., Jaenisch F.R.F., Brito K.C.T., Carvalho D., Lovato M. & Brito B.G. 2016. Laboratório de Saúde E-mail:das Aves e Inovação Tecnológica, Instituto de Pesquisas Veterinárias Desidério Finamor, FEPAGRO Saúde Animal, Estrada do Conde 6000, Eldorado do Sul, RS 92990-000, Brazil. [email protected] This study represents the first phylogenetic analysis of avian poxvirus recovered from- turkeys in Brazil. The clinical disorders related to fowlpox herein described occurred in a turkey housing system. The birds displaying characteristic pox lesions which were ob served on the neck, eyelids and beak of the turkeys. Four affected turkeys were randomly chosen, euthanized and necropsied. Tissues samples were submitted for histopathologicalP4b analysis and total DNA was further extracted, amplified by conventional PCR, sequenced- and phylogenetically analyzed. Avian poxviruses specific PCR was performed basedP4b on core protein gene sequence. The histological analysis revealed dermal inflammatory pro- cess, granulation tissue, hyperplasia of epithelial cells and inclusion bodies. The ® gene was detected in all samples. Sequencing revealed a 100% nucleotide and amino acid se quence identity among the samples, andAvipoxvirus the sequences were deposited in GenBank .
    [Show full text]
  • A Multiplex PCR for Detection of Poxvirus and Papillomavirus in Cutaneous Warts from Live Birds and Museum Skins
    Submitted, accepted and published by AVIAN DISEASES 55:545–553, 2011 A Multiplex PCR for Detection of Poxvirus and Papillomavirus in Cutaneous Warts from Live Birds and Museum Skins a AG BG C D C E C J . Pe´rez-Tris, R. A. J. Williams, E. Abel-Ferna´ndez, J. Barreiro, J. J. Conesa, J. Figuerola, M. Martinez-Mart´ınez, A CF A. Ram´ırez, and L. Benitez ADepartmento de Zoolog´ıa y Antropolog´ıa F´ısica, Facultad de Biolog´ıa, Universidad Complutense de Madrid, C/ Jose Antonio Novais, 28040, Madrid, Spain BNatural History Museum and Biodiversity Research Center, University of Kansas, Lawrence, KS 66045 CDepartmento de Microbiolog´ıa III, Facultad de Biolog´ıa, Universidad Complutense de Madrid, C/ Jose Antonio Novais, 28040, Madrid, Spain DMuseo Nacional de Ciencias Naturales, C/Jose´ Gutie´rrez Abascal 2, 28006 Madrid, Spain EEstacion Biologica de Don˜ ana, Consejo Superior de Investigaciones Cient´ıficas, 41013 Seville, Spain SUMMARY. Viral cutaneous lesions are frequent in some bird populations, though we are generally ignorant of the causal agent. In some instances, they represent a threat to livestock and wildlife health. We present here a multiplex PCR which detects and distinguishes infection by two such agents, avipoxviruses and papillomaviruses, in avian hosts. We assayed biopsies and superficial skin swabs from field and preserved museum skin specimens. Ninety-three percent of samples from symptomatic specimens tested positive for the presence of avipox (n 5 23) or papillomavirus (n 5 5). Sixteen and five sequences, corresponding to the P4b and L1 genes, were obtained from avipox and papillomavirus, respectively.
    [Show full text]
  • Taqman Quantitative Real-Time PCR for Detecting Avipoxvirus DNA in Various Sample
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.09.983460; this version posted March 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Baek et al. 1 TaqMan quantitative real-time PCR for detecting Avipoxvirus DNA in various sample 2 types from hummingbirds 3 Hanna E. Baek¹, Ravinder N. Sehgal¹, Ruta R. Bandivadekar², Pranav Pandit3, Michelle Mah², 4 and Lisa A. Tell² 5 6 1Dept. of Biology, San Francisco State University, San Francisco, CA, USA 7 ²Dept of Medicine and Epidemiology, School of Veterinary Medicine, University of California, 8 Davis, CA, USA 9 3EpiCenter for Disease Dynamics, One Health Institute, School of Veterinary Medicine, 10 University of California, Davis, CA, USA 11 12 Co-Corresponding Authors: 13 Lisa A. Tell ([email protected]) 14 Ravinder Sehgal ([email protected]) 15 16 17 18 19 20 21 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.09.983460; this version posted March 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Baek et al. 22 Abstract 23 Background: 24 Avian pox is a viral disease documented in a wide range of bird species. Disease related 25 detrimental effects can cause dyspnea and dysphagia, therefore birds with high metabolic 26 requirements, such as hummingbirds, are especially vulnerable.
    [Show full text]
  • The Complete Genome Sequences of Poxviruses Isolated from a Penguin
    Offerman et al. BMC Genomics 2014, 15:463 http://www.biomedcentral.com/1471-2164/15/463 RESEARCH ARTICLE Open Access The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses Kristy Offerman1†, Olivia Carulei1†, Anelda Philine van der Walt2, Nicola Douglass1 and Anna-Lise Williamson1,3,4* Abstract Background: Two novel avipoxviruses from South Africa have been sequenced, one from a Feral Pigeon (Columba livia) (FeP2) and the other from an African penguin (Spheniscus demersus) (PEPV). We present a purpose-designed bioinformatics pipeline for analysis of next generation sequence data of avian poxviruses and compare the different avipoxviruses sequenced to date with specific emphasis on their evolution and gene content. Results: The FeP2 (282 kbp) and PEPV (306 kbp) genomes encode 271 and 284 open reading frames respectively and are more closely related to one another (94.4%) than to either fowlpox virus (FWPV) (85.3% and 84.0% respectively) or Canarypox virus (CNPV) (62.0% and 63.4% respectively). Overall, FeP2, PEPV and FWPV have syntenic gene arrangements; however, major differences exist throughout their genomes. The most striking difference between FeP2 and the FWPV-like avipoxviruses is a large deletion of ~16 kbp from the central region of the genome of FeP2 deleting a cc-chemokine-like gene, two Variola virus B22R orthologues, an N1R/p28-like gene and a V-type Ig domain family gene. FeP2 and PEPV both encode orthologues of vaccinia virus C7L and Interleukin 10. PEPV contains a 77 amino acid long orthologue of Ubiquitin sharing 97% amino acid identity to human ubiquitin.
    [Show full text]
  • Construction of a Recombinant Avipoxvirus Expressing
    Zanotto et al. Virol J (2021) 18:50 https://doi.org/10.1186/s12985-021-01519-x RESEARCH Open Access Construction of a recombinant avipoxvirus expressing the env gene of Zika virus as a novel putative preventive vaccine Carlo Zanotto1, Francesca Paolini2, Antonia Radaelli1*† and Carlo De Giuli Morghen3† Abstract Background: Zika virus (ZIKV) has been declared a public health emergency that requires development of an efec- tive vaccine, as it might represent an international threat. Methods: Here, two novel DNA-based (pVAXzenv) and fowlpox-based (FPzenv) recombinant putative vaccine can- didates were constructed that contained the cPrME genes of ZIKV. The env gene inserted into the fowlpox vector was verifed for correct transgene expression by Western blotting and by immunofuorescence in diferent cell lines. The production of virus-like particles as a result of env gene expression was also demonstrated by electron microscopy. BALB/c mice were immunosuppressed with dexamethasone and immunized following a prime–boost strategy in a heterologous protocol where pVAXzenv was followed by FPzenv, to evaluate the immunogenicity of the Env protein. The mice underwent a challenge with an epidemic ZIKV after the last boost. Results: These data show that the ZIKV Env protein was correctly expressed in both normal human lung fbroblasts (MRC-5 cells) and green monkey kidney (Vero) cells infected with FPzenv, and that the transgene expression lasted for more than 2 weeks. After mucosal administration of FPzenv, the immunized mice showed specifc and signifcantly higher humoral responses compared to the control mice. However, virus neutralizing antibodies were not detected using plaque reduction assays.
    [Show full text]
  • Prevalence and Genetic Diversity of Avipoxvirus in House Sparrows in Spain
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UDORA - University of Derby Online Research Archive RESEARCH ARTICLE Prevalence and Genetic Diversity of Avipoxvirus in House Sparrows in Spain Jorge Ruiz-MartõÂnez1, Martina Ferraguti2, Jordi Figuerola2,3, Josue MartõÂnez-de la Puente2,3, Richard Alexander John Williams4¤, Amparo Herrera-Dueñas4, Jose Ignacio Aguirre4, Ramo n Soriguer2,3, Clara Escudero1, MichaeÈl Andre Jean Moens4, Javier PeÂrez-Tris4, Laura BenõÂtez1* 1 Departamento de MicrobiologõÂa III, Facultad de BiologõÂa, Universidad Complutense de Madrid, Madrid, Spain, 2 EstacioÂn BioloÂgica de Doñana, Consejo Superior de Investigaciones CientõÂficas, Sevilla, Spain, 3 CIBER EpidemiologõÂa y Salud PuÂblica (CIBERESP), Spain, 4 Departamento de ZoologõÂa y AntropologÂõa a1111111111 FõÂsica, Facultad de BiologõÂa, Universidad Complutense de Madrid, Madrid, Spain a1111111111 a1111111111 ¤ Current Address: Centre for Ecology and Evolution in Microbial Model Systems, Linnaeus University, a1111111111 Kalmar, Sweden a1111111111 * [email protected] Abstract OPEN ACCESS Avipoxvirus (APV) is a fairly common virus affecting birds that causes morbidity and mortal- Citation: Ruiz-MartõÂnez J, Ferraguti M, Figuerola J, ity in wild and captive birds. We studied the prevalence of pox-like lesions and genetic diver- MartõÂnez-de la Puente J, Williams RAJ, Herrera- sity of APV in house sparrows (Passer domesticus) in natural, agricultural and urban areas Dueñas A, et al. (2016) Prevalence and Genetic in southern Spain in 2013 and 2014 and in central Spain for 8 months (2012±2013). Overall, Diversity of Avipoxvirus in House Sparrows in Spain. PLoS ONE 11(12): e0168690. doi:10.1371/ 3.2% of 2,341 house sparrows visually examined in southern Spain had cutaneous lesions journal.pone.0168690 consistent with avian pox.
    [Show full text]
  • Epidemiology and Disease Burden of Infections with Encephalitic Flaviviruses
    Epidemiology and Disease Burden of Infections with Encephalitic Flaviviruses John T. Roehrig, Ph.D. Arboviral Diseases Branch Division of Vector-Borne Diseases CDC, USA Viruses in the Genus Flavivirus (Family Flaviviridae) Tick-borne viruses Mammalian tick-borne virus group (TBE, POW) Seabird tick-borne virus group Mosquito-borne viruses Aroa virus group Dengue virus group Japanese encephalitis virus group Kokobera virus group Ntaya virus group Spondweni virus group Yellow fever virus group Viruses with no known arthropod vector Entebbe bat virus group Modoc virus group Rio Bravo virus group Tentative Species in Genus Tanama bat virus Cell fusing agent Kamiti River virus Culex flavivirus Serocomplexes of Flaviviruses 1. Tick-borne encephalitis – TBE (Eu, FE, Sib), POW, KFD, OHF 2. Rio Bravo – MOD 3. Japanese encephalitis – JE, SLE, MVE, WN(KUN) 4. Spondweni – ZIK 5. Ntaya – ITM 6. Banzi – EHV 7. Dengue – 1, 2, 3, 4 8. Yellow fever, Rocio, Ilheus, Bussuquara, Sepik, Wesselsbron Flaviviral Encephalitides: General Clinical Description • Asymptomatic or mild flu-like illness • Fever, lymphadenopathy, headache, abdominal pain, vomiting, rash, conjunctivitis • Incubation period usually 5 to 15 days • CNS involvement and death in minority of cases – sequellae can occur • No specific treatment Prevention and Control of Flaviviral Infections • Vector control – source reduction, larvaciding, adulticiding • Exposure control – avoid mosquito and tick bites, repellents • Vaccination – JEV and TBEV TBEV: Background and Epidemiology • First isolated
    [Show full text]
  • Baculovirus Molecular Biology
    1 2 Baculovirus Molecular Biology Fourth Edition George F. Rohrmann Department of Microbiology Oregon State University Corvallis, OR 97331-3804 [email protected] https://www.ncbi.nlm.nih.gov/books/NBK543458/ Copyright G. F. Rohrmann 2019 Citation: Rohrmann GF. Baculovirus Molecular Biology [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2019. 3 4 Table of Contents Preface 7 Chapters 1. Introduction to the baculoviruses, their taxonomy, and evolution 11 2. Structural proteins of baculovirus occlusion bodies and virions 25 3. The baculovirus replication cycle: Effects on cells and insects 53 4. Early events in infection: Virus transcription 73 5. DNA replication and genome processing 83 6. Baculovirus late transcription 105 7. Baculovirus infection: The cell cycle and apoptosis 117 8. Host resistance, susceptibility and the effect of viral infection on host molecular biology 125 9. Baculoviruses as insecticides; three examples 133 10. Baculovirus expression technology: Theory and application 139 11. Baculoviruses, retroviruses, DNA transposons (piggyBac), and insect cells 151 12. The AcMNPV genome: gene content, conservation, and function 165 13. Selected baculovirus genes without orthologs in the AcMNPV genome: Conservation and function 221 14. Glossary 227 5 6 Preface from fourth edition George Rohrmann, PhD August 1, 2019 This is the 4th edition of a book that was initiated with the annotation of the function of all the genes in the most commonly studied baculovirus, AcMNPV. It has been almost six years since I reviewed this literature. As a measure of the research that has occurred over this time, Chapter 12 which reviews all the presumptive genes in the AcMNPV genome went from 481 references to 582, a 21% increase.
    [Show full text]
  • Viruses Status January 2013 FOEN/FOPH 2013 1
    Classification of Organisms. Part 2: Viruses Status January 2013 FOEN/FOPH 2013 1 Authors: Prof. Dr. Riccardo Wittek, Dr. Karoline Dorsch-Häsler, Julia Link > Classification of Organisms Part 2: Viruses The classification of viruses was first published in 2005 and revised in 2010. Classification of Organisms. Part 2: Viruses Status January 2013 FOEN/FOPH 2013 2 Name Group Remarks Adenoviridae Aviadenovirus (Avian adenoviruses) Duck adenovirus 2 TEN Duck adenovirus 2 2 PM Fowl adenovirus A 2 Fowl adenovirus 1 (CELO, 112, Phelps) 2 PM Fowl adenovirus B 2 Fowl adenovirus 5 (340, TR22) 2 PM Fowl adenovirus C 2 Fowl adenovirus 10 (C-2B, M11, CFA20) 2 PM Fowl adenovirus 4 (KR-5, J-2) 2 PM Fowl adenovirus D 2 Fowl adenovirus 11 (380) 2 PM Fowl adenovirus 2 (GAL-1, 685, SR48) 2 PM Fowl adenovirus 3 (SR49, 75) 2 PM Fowl adenovirus 9 (A2, 90) 2 PM Fowl adenovirus E 2 Fowl adenovirus 6 (CR119, 168) 2 PM Fowl adenovirus 7 (YR36, X-11) 2 PM Fowl adenovirus 8a (TR59, T-8, CFA40) 2 PM Fowl adenovirus 8b (764, B3) 2 PM Goose adenovirus 2 Goose adenovirus 1-3 2 PM Pigeon adenovirus 2 PM TEN Turkey adenovirus 2 TEN Turkey adenovirus 1, 2 2 PM Mastadenovirus (Mammalian adenoviruses) Bovine adenovirus A 2 Bovine adenovirus 1 2 PM Bovine adenovirus B 2 Bovine adenovirus 3 2 PM Bovine adenovirus C 2 Bovine adenovirus 10 2 PM Canine adenovirus 2 Canine adenovirus 1,2 2 PM Caprine adenovirus 2 TEN Goat adenovirus 1, 2 2 PM Equine adenovirus A 2 Equine adenovirus 1 2 PM Equine adenovirus B 2 Equine adenovirus 2 2 PM Classification of Organisms.
    [Show full text]
  • Supporting Information
    Supporting Information Wu et al. 10.1073/pnas.0905115106 20 15 10 5 0 10 15 20 25 30 35 40 Fig. S1. HGT cutoff and tree topology. Robinson-Foulds (RF) distance [Robinson DF, Foulds LR (1981) Math Biosci 53:131–147] between viral proteome trees with different horizontal gene transfer (HGT) cutoffs h at feature length 8. Tree distances are between h and h-1. The tree topology remains stable for h in the range 13–31. We use h ϭ 20 in this work. Wu et al. www.pnas.org/cgi/content/short/0905115106 1of6 20 18 16 14 12 10 8 6 0.0/0.5 0.5/0.7 0.7/0.9 0.9/1.1 1.1/1.3 1.3/1.5 Fig. S2. Low complexity features and tree topology. Robinson-Foulds (RF) distance between viral proteome trees with different low-complexity cutoffs K2 for feature length 8 and HGT cutoff 20. The tree topology changes least for K2 ϭ 0.9, 1.1 and 1.3. We choose K2 ϭ 1.1 for this study. Wu et al. www.pnas.org/cgi/content/short/0905115106 2of6 Table S1. Distribution of the 164 inter-viral-family HGT instances bro hr RR2 RR1 IL-10 Ubi TS Photol. Total Baculo 45 1 10 9 11 1 77 Asco 11 7 1 19 Nudi 1 1 1 3 SGHV 1 1 2 Nima 1 1 2 Herpes 48 12 Pox 18 8 2 3 1 3 35 Irido 1 1 2 4 Phyco 2 3 2 1 8 Allo 1 1 2 Total 56 8 35 24 6 17 14 4 164 The HGT cutoff is 20 8-mers.
    [Show full text]